Back
BioCryst Pharmaceuticals Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
33
BCRX
BioCryst Pharmaceuticals
Last Price:
7.78
Seasonality Move:
8.68%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BioCryst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.8 | Sell |
| 20-day SMA: | 7.79 | Sell |
| 50-day SMA: | 7.78 | Sell |
| 200-day SMA: | 6.46 | Buy |
| 8-day EMA: | 7.74 | Buy |
| 20-day EMA: | 7.76 | Buy |
| 50-day EMA: | 7.69 | Buy |
| 200-day EMA: | 7.04 | Buy |
BioCryst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 50.38 | Buy |
| Chaikin Money Flow: | 983085 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.32 - 8.08) | Buy |
| Bollinger Bands (100): | (6.89 - 8.11) | Buy |
BioCryst Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioCryst Pharmaceuticals Stock
Is BioCryst Pharmaceuticals Stock a Buy?
- BioCryst Pharmaceuticals share price is 7.78 while BCRX 8-day simple moving average is 7.80, which is a Sell signal.
- The stock price of BCRX is 7.78 while BioCryst Pharmaceuticals 20-day SMA is 7.79, which makes it a Sell.
- BioCryst Pharmaceuticals 50-day simple moving average is 7.78 while BCRX share price is 7.78, making it a Sell technically.
- BCRX stock price is 7.78 and BioCryst Pharmaceuticals 200-day simple moving average is 6.46, creating a Buy signal.
BCRX Technical Analysis vs Fundamental Analysis
Sell
33
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals a Buy or a Sell?
-
BioCryst Pharmaceuticals stock is rated a Sell
The current BioCryst Pharmaceuticals [BCRX] share price is $7.78. The Score for BCRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
BioCryst Pharmaceuticals Stock Info
Market Cap:
1.61B
Price in USD:
7.78
Share Volume:
1.57M
BioCryst Pharmaceuticals 52-Week Range
52-Week High:
8.88
52-Week Low:
4.03
Sell
33
BioCryst Pharmaceuticals (BCRX)
is a Sell
BioCryst Pharmaceuticals Share Price Forecast
-
What is the BioCryst Pharmaceuticals stock price today?
The BioCryst Pharmaceuticals stock price is 7.78 USD today. -
Will BCRX stock go up or go down?
BioCryst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is BioCryst Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioCryst Pharmaceuticals is overvalued.
Is BioCryst Pharmaceuticals Stock a Buy?
- BioCryst Pharmaceuticals share price is 7.78 while BCRX 8-day exponential moving average is 7.74, which is a Buy signal.
- The stock price of BCRX is 7.78 while BioCryst Pharmaceuticals 20-day EMA is 7.76, which makes it a Buy.
- BioCryst Pharmaceuticals 50-day exponential moving average is 7.69 while BCRX share price is 7.78, making it a Buy technically.
- BCRX stock price is 7.78 and BioCryst Pharmaceuticals 200-day simple moving average is 7.04, creating a Buy signal.
Fundamental Analysis of BioCryst Pharmaceuticals
Is BioCryst Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.35 per share.
Technical Analysis of BioCryst Pharmaceuticals
Should I short BioCryst Pharmaceuticals stock?
- BCRX Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting BioCryst Pharmaceuticals is a Buy
- BioCryst Pharmaceuticals Relative Strength Index (RSI) is 50.38, which suggest BioCryst Pharmaceuticals is overbought
- The Bollinger Bands (25) for BioCryst Pharmaceuticals is (7.32 - 8.08), which suggest BioCryst Pharmaceuticals is a Buy
- The Bollinger Bands (100) for BioCryst Pharmaceuticals is (6.89 - 8.11), which suggest BioCryst Pharmaceuticals is a Buy
* BioCryst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.